• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Premarket Approval (PMA)

  • Print
  • Share
  • E-mail
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC | Inspections

New Search Back to Search Results
Note: this medical device record is a supplement. The device description may have changed. Be sure to look at the original PMA to get an up-to-date view of this device.
Classification Namedefibrillator, implantable, dual-chamber
Generic Nameimplantable cardioverter-defibrillator with active housing
PMA NumberP980049
Supplement NumberS009
Date Received05/22/2003
Decision Date07/02/2003
Product Code
MRM[ Registered Establishments with MRM ]
Advisory Committee Cardiovascular
Supplement Typereal-time process
Supplement Reason design change - minor
Expedited Review Granted? No
Combination Product No
Approval Order Statement 
Approval for down-sized versions of the alto models dr 614 and vr 615 implantable cardioverter defibrillatos (icds), modifications to the orchestra application software, and the addition of separately packaged is-1 and df-1 port plugs. The icd devices, as modified, will be marketed under the trade names alto dr model 624 icd and alto vr model 625, and are indicated for use in patients who are at risk of sudden death due to ventricular arrhythmias and have experienced one of the following situations: (1) survival of at least one episode of cardiac arrest (manifested by loss of consciousness) due to a ventricular tachyarrhythmia; (2) recurrent, poorly tolerated, sustained ventricular tachycardia (vt). Note: the clinical outcome for hemodynamically stable vt patients is not fully known. Safety and effectiveness studies have not been conducted. The modified application software will be marketed under the trade name orchestra application software (elaview 1. 06 ug2).